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http://www.retrovirology.com/content/9/1/41RESEARCH Open AccessThe prototype foamy virus protease is active
independently of the integrase domain
Ralf Spannaus1, Maximilian J Hartl2, Birgitta M Wöhrl2, Axel Rethwilm1 and Jochen Bodem1*Abstract
Background: Recently, contradictory results on foamy virus protease activity were published. While our own results
indicated that protease activity is regulated by the viral RNA, others suggested that the integrase is involved in the
regulation of the protease.
Results: To solve this discrepancy we performed additional experiments showing that the protease-reverse
transcriptase (PR-RT) exhibits protease activity in vitro and in vivo, which is independent of the integrase domain. In
contrast, Pol incorporation, and therefore PR activity in the viral context, is dependent on the integrase domain. To
further analyse the regulation of the protease, we incorporated Pol in viruses by expressing a GagPol fusion protein,
which supported near wild-type like infectivity. A GagPR-RT fusion, lacking the integrase domain, also resulted in
wild-type like Gag processing, indicating that the integrase is dispensable for viral Gag maturation. Furthermore, we
demonstrate with a trans-complementation assays that the PR in the context of the PR-RT protein supports in trans
both, viral maturation and infectivity.
Conclusion: We provide evidence that the FV integrase is required for Pol encapsidation and that the FV PR activity
is integrase independent. We show that an active PR can be encapsidated in trans as a GagPR-RT fusion protein.
Keywords: Foamy virus, Regulation of protease activity, PARM, Integrase, GagPol fusion proteinBackground
Foamy viral assembly and maturation differs in many ways
from the orthoretroviral counterpart. Foamy viruses (FVs)
express the Pol protein from a specific transcript and not
from a Gag-Pol precursor [1-6]. This leads to the expres-
sion of a separate Pol polyprotein consisting of a protease
(PR), reverse transcriptase (RT) and integrase (IN) domain.
Consequently, the assembly of FVs is complex since inter-
action of the viral RNA with Pol has been shown to be
required for Pol uptake [7,8]. Several PR cleavage sites in
Pol have been determined in vitro [9], but the in vivo mat-
uration of foamy viral proteins appears to be very limited
as compared to orthoretroviruses. Single cleavage sites
were identified in vivo in both, Gag and Pol. Pol cleavage
results in the free IN domain and a PR-RT fusion protein,
whereas a p3 peptide is cleaved off from the carboxyl ter-
minal end of Gag [10]. Despite the limited in vivo cleavage,
the activity of the PR has to be tightly controlled to allow* Correspondence: jochen.Bodem@vim.uni-wuerzburg.de
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reproduction in any medium, provided the orpackaging of the full-length Gag and Pol precursor pro-
teins into the virus. The PR activity is essential for viral in-
fectivity [5]. The separate PR domain was shown to exhibit
only a weak tendency to form active dimers in vitro
[11,12]. PR dimer formation and activation are achieved,
as we have shown recently, by the activation of the PR by
a specific interaction of PR-RT with the viral PR activation
RNA motif (PARM) [11,13]. PARM is located in the IN
region of the viral genome [7,11]. Recently, Lee et al. [13]
reported that PR activity requires the IN domain. Add-
itionally, IN was suggested to be essential for dimerization
of the Pol protein, which subsequently is needed for PR ac-
tivity. Here, we wanted to re-analyse the Pol domains’
requirements for PR activity both in vitro and in vivo,
using a novel approach to target Pol independently of
RNA or Pol domains into FV particles.
Results and discussion
PR-RT exhibits PR activity in an RNA dependent way
in vitro
In two in vitro assays the ability of Prototype foamy virus
(PFV) (previously known as human foamy virus) PR-RTral Ltd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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between the streptococcal protein G (GB1) and the green
flourescence protein (GFP) was investigated [12]. The
first assay identifies the PR cleavage products after incu-
bation of the GB1-GFP substrate with PFV PR-RT and
RNA containing the PARM (RNAPARM) by SDS poly-
acrylamide gel electrophoresis (PAGE) (Figure 1A). In a
second assay the conversion of the PR substrate was fol-
lowed by measuring the differences in fluorescence an-
isotropy of the GFP moiety in the GB1-GFP fusion
protein and the free GFP cleavage product after the suc-
cessive addition of PFV PR-RT and RNAPARM (Figure 1B).
Both assays show that PR cleavage is depending on the
presence of RNAPARM. However, PR cleavage occurs in
the complete absence of IN, indicating that IN is not
required for PR activity in vitro. Nevertheless, we cannot
rule out that the presence of IN might lead to more
stable dimers or oligomers, thus enhancing PR activity.
Therefore the following in vivo experiments were
conducted.
PR-RT exhibits PR activity in vivo
In order to analyse the influence of the IN domain on
PR activity in vivo a stop codon was inserted down-
stream of the RT-IN cleavage site in a codon optimized
PFV pol expression plasmid (pcoPP) by site directed mu-
tagenesis leading to the pPR-RT plasmid. HEK 293 T
cells were transfected with the codon optimized gag ex-
pression plasmid (pcoPG4), increasing pcoPP or pPR-RT
amounts with or without a foamy viral vector genome
encoding gfp (pMD9) (Figure 2A). Pol and gag expres-
sion and PR activity were analysed by Western blottingBA
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Figure 1 Proteolytic activity of PFV PR-RT in vitro. (A) The GB1-GFP sub
absence of RNAPARM. Reaction products were separated on 10% BisTris gels
indicated on the left; S: uncleaved substrate. (B) For kinetic studies the con
anisotropy. The substrate was incubated at 37°C. PFV PR-RT and RNAPARM wusing Gag and Pol specific monoclonal antibodies
[14,15]. Both, Pol as well as PR-RT, promoted Gag cleav-
age at the p3 cleavage site (Figure 2A). Transfection of
increasing amounts of the Pol- or PR-RT-specific con-
structs, respectively, resulted in an increase in cleavage
efficiency, which is probably due to overexpression of pol
or PR-RT in the vector based system, as shown previ-
ously [11]. Nevertheless, cleavage of Gag or Pol was fur-
ther enhanced by the expression of the vector genome,
indicating the requirement of PARM for optimal PR ac-
tivity [11].
Comparing both, Pol- and PR-RT-mediated Gag proces-
sing, a higher PR activity in Pol expressing cells was
observed. This could be due to higher Pol expression levels
(Figure 2). However, it is more likely that the somewhat
lower PR activity with PR-RT was the result of a
decrease of PR-RT incorporation into cell-associated
or intracellular viruses, as IN is required for FV Pol
encapsidation.
The IN domain is required for pol encapsidation
To confirm this result in the context of the PFV proviral
clone (pHSRV13), the complete IN domain downstream
of the RT/IN cleavage site was deleted. BHK cells were
transfected with the proviral plasmids pHSRV13 or
pHSRV13ΔIN. Supernatants were collected after two
days and viruses were pelleted through a sucrose cush-
ion. The pelleted viruses were lysed in RIPA buffer. Gag
and Pol proteins were analysed by Western blotting
(Figure 2B). After deletion of the IN domain some Gag
cleavage was observed, (Figure 2B), leading to the
conclusion that the IN might enhance the PR activity,+PRRT +RNAPARM
strate was incubated at 37°C with PFV PR-RT in the presence or
. M: molecular weight marker, the sizes of the standard proteins are
version of the GB1-GFP substrate was observed by fluorescence
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Figure 2 In vivo cell culture PR-activity assays and deletion of
integrase domain in the proviral context. (A) HEK 293 T cells
were cotransfected either with a codon-optimized PFV pcoPP or a
pPR-RT expression plasmid, 0.5 μg of the pcoPG4 as PR substrate
and the gfp-encoding pMD9 as source for viral RNA (DNA amounts
are indicated in [μg]). PR activity and Pol expression was determined
by Gag (upper panel) and Pol (middle panel) Western blotting
analysis using monoclonal antibodies. Determination of the GAPDH
concentration served as loading control (lower panel). Positions of
the molecular size makers are indicated. (B) The IN is required for Pol
encapsidation. Viruses isolated from cell culture supernatants and
cellular lysates were analysed for Pol and Gag expression and
maturation by Western blotting.
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PR-RT incorporation can be observed in the recent pub-
lication by Lee at al ([13] Figure 1D) as well, underlining
our results. In addition, our IN deletion mutants showed
a strong decrease in cellular PR-RT amounts. Again, this
is in line with the results shown previously [13].
In-frame expression of gag and pol gives rise to infectious
virus and genome independent pol encapsidation
To study Gag processing in viral particles in an IN inde-
pendent way, we first fused the Gag and Pol reading frame,
thereby coupling FV Pol uptake to Gag. A similar ap-
proach for FV Pol expression in the proviral context was
published recently [16]. In doing so, we sought to showthat the Pol or PR-RT uptake can take place as a GagPol
fusion protein. Thus, we analysed whether FV Pol can be
incorporated into particles as a Gag-Pol fusion protein and
whether this results in the formation and release of infec-
tious viral particles. In a first step the codon optimized
Gag and Pol ORFs were fused and a p3-Gag cleavage site
(CS) was inserted upstream of the PR-domain leading to a
PFV Gag-p3CS-Pol expression plasmid called pGagPol
(Figure 3A). pGagPol is devoid of any RNA sequences that
have been shown to be required for PR activity. HEK
293 T cells were cotransfected with the GFP encoding
pMD9 as a source for viral RNA, with the env expression
plasmid (pcoPE), pGagPol and additionally with 0.25 or
0.5 μg of the codon optimized Gag-encoding plasmid
pcoPG4 since the Gag/Pol ratio might be important for
proper virus morphology (Figure 3B and C). In addition,
HEK 293 T cells were cotransfected with the FV vector
system (VS) consisting of pcoPE, pcoPP, pcoPG4, and
pMD9 as described before [17]. The supernatants were
titrated 2 days after transfection and transduction rates
were determined (Figure 3B). Surprisingly, transfections of
cells with pcoPE, pMD9 and the pGagPol fusion plasmid
even in the absence of the additional gag expression
plasmid led to viral titers of about 1/3 of the vector system
control. Viral titers could even be raised by co-transfecting
cells with increasing amounts of pcoPG4 (Figure 3B).
These experiments show that the expression of a GagPol
fusion protein leads to infectious FVs and a separate Pol is
not required in the vector context. The Gag and Pol
expression and processing of the GagPol precursor protein
alone or with additional Gag was analysed by Western
blotting using monoclonal antibodies against Gag and Pol
as described before [18] (Figure 3C). This analysis revealed
a wt-like Gag processing, whereas an additional Pol pro-
duct, probably consisting of p3-PR-RT, was detected.
It was shown previously that FV Gag release is dependent
on the viral Env and that Pol encapsidation requires the
viral genome [19]. To further investigate whether Pol up-
take is genome dependent and GagPol particle release is
Env-dependent, we analysed if Env or pMD9 is required for
particle release. Therefore, HEK 293 Tcells were transfected
as described above with either the vector system or with
pGagPol in the presence or absence of pMD9, harbouring
the viral genome, or pcoPE expressing Env (Figure 3D). In
order to increase particle formation, the cells were cotrans-
fected with the gag expression vector pcoPG4 and the
pGagPol plasmid. Viruses were partially purified by ultra-
centrifugation through a sucrose cushion. Cellular and viral
Pol and Gag processing and amounts were analysed by
Western blotting (Figure 3C). This analysis revealed that
more Pol was incorporated into virus particles that were
derived from expressing cells as compared to cells trans-
fected with the vector system, indicating that FVs tolerate
higher Pol incorporation than seen with the wt. In contrast
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Figure 3 Analysis of virus infectivity and PR activity in vivo using different GagPol-fusion proteins. (A) A schematic diagram of the GagPol
precursor protein is depicted on top of the panels: CS, PR cleavage site. (B) Comparison of the virus titer of FV codon optimized vector system
(VS) [11] or the GagPol fusion plasmid cotransfected with an env expression construct and pMD9 as gfp-encoding genome. Additional amounts of
a gag expression plasmid (pcoPG4) used for cotransfections are indicated. The transfected DNA amounts are indicated in [μg]. Transfections were
performed in triplicate assays. The error bars represent the standard deviation. (C) Western blotting analysis of the samples from Figure 3A. The
cellular and viral Gag/Pol amounts and processing using Gag and RT specific antibodies were analysed (VS: FV vector system [11]). (D) The virus
release of GagPol fusion is Env dependent but genome independent and the processing of Gag is IN independent. Western blotting analysis of
the cellular and viral Gag/Pol amounts and processing. HEK 293 T (2×105) cells were transfected with pcoPE, pMD9, pcoPG4, and either pGagPol
or pGagPR-RT. The transfected DNA amounts are indicated in [μg]. Analysis of the GAPDH expression served as a loading control.
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In addition, Pol was not cleaved off from Gag first and sub-
sequently incorporated in a RNA dependent way, since Pol
was encapsidated even in the absence of the viral genome.(Figure 3D, compare lanes 3 (separate Pol without viral gen-
ome)) and 7 (GagPol fusion protein without viral genome).
Env was required for particle release of cells transfected ei-
ther with vector system or pGagPol (Figure 3D, lanes 1 & 2
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Figure 4 Co-expression of a mutated GagPol fusion protein with an inactive PR domain together with a GagPR-RT fusion protein leads
to both maturated Gag and Pol proteins and viral infectivity. (A) Scheme of the plasmids used in this experiment. (B) Western blot from
both transfected cells (upper three panels) and partially purified viruses (lower panel) using αGag and αPol monoclonal antibodies. HEK 293 T cells
were transfected with pMD9, pcoPE and pcoPG4 and either pGagPol (lane 1) or a combination of pGagIN and pGagPR-RT (lane 2) or pGagIN and
pGagPolD/A (lane 3). The transfected DNA amounts are indicated in [μg]. Determination of cellular GAPDH amounts served as loading control. (C)
Viral titers were determined on BHK-ll indicator cells. Transfections were performed in triplicate assays. The error bars represent the standard
deviation. The transfected DNA amounts are indicated in [μg].
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separate Pol is not required for FV assembly and that a
Gag-Pol fusion protein results in infectious viruses.
The viral GagPR-RT fusion protein exhibits PR activity
Having established that a GagPol fusion protein leads to
virus particles, a codon optimized GagPR-RT expression
plasmid was created by PCR to investigate PR activity.
This plasmid encodes the complete Gag, PR and RT
ORFs followed by a stop codon. HEK 293 T cells weretransfected with pcoPE, pMD9, pcoPG4, and either
pGagPol or pGagPR-RT. Gag and Pol amounts as well as
Gag processing of the harvested viruses was analysed by
Western blotting (Figure 3D, lanes 9 and 10). The PR ac-
tivity in the context of the codon optimized Pol con-
structs is not strictly dependent on the viral RNA, due to
the high over-expression rate of pol [11]. Viruses from
both, pGagPol and pGagPR-RT transfected cells, showed
similar Gag processing, indicating that the presence of
the IN domain is not crucial for PR activity.
Spannaus et al. Retrovirology 2012, 9:41 Page 6 of 8
http://www.retrovirology.com/content/9/1/41PR-RT in trans is sufficient for PR mediated cleavage and
infectivity
Since expression of GagPR-RT together env, gag and the
vector genome led to wt-like Gag cleavage (Figure 3D),
two trans-complementation assays were performed. The
PR domain was expressed and encapsidated separately
from the IN domain in both assays. First, we co-transfected
HEK 293 T cells with the GagIN fusion together with a
GagPR-RT fusion construct and with the other compo-
nents of the vector system. The fused Gag domain should
guarantee the encapsidation of the PR-RT and IN domains.
Gag and RT expression and processing were deter-
mined in cellular lysates (Figure 4B). The Gag matu-
ration was confirmed by Western blots of partially
purified viruses. This experiment indicates that PR-RT
is capable of cleaving the Gag precursor protein
(Figure 4B). However, these transfections resulted in a
significant loss of infectivity (approximately 3 logs)
probably due to a failure in genome incorporation
(Figure 4C).
Therefore, in a second approach the plasmid pGagPolD/A
was used as IN source in the context of the Pol protein. The
pGagPolD/A plasmid encodes a GagPol fusion protein
with a mutation in the PR-active site (Asp24>Ala) [5]
(Figure 4A). HEK 293 T cells were co-transfected with
pGagPol alone or with pGagPolD/A and pGagPR-RT, as a
PR source (Figure 4A and B). Western blotting analysis
showed maturation of both cellular and viral Gag proteins.
Furthermore, analysis of the viral infectivity revealed that
both, recombinant viruses comprising an encapsidated
GagPR-RT protein were infectious (Figure 4C) although
viral titers (104/ml) were significantly lower than those of
the wt (106/ml). These experiments prove clearly that the
IN domain in cis is not necessary for PR activity, since we
show here that the FV PR in trans is sufficient for viral
maturation.
We provide evidence that the IN domain is required for
efficient pol expression and for Pol encapsidation. Recap-
itulatory, all publications containing data on FV Gag and
Pol cleavage in the presence or absence of the viral
genome confirm the necessity of the viral RNA for PR
activity. [11,20-22]. In addition, we show that a Gag-Pol
fusion protein can give rise to infectious viruses and that
the expression of a separate Pol is not required for FV
infecti-vity. Furthermore, with the GagPol fusion protein
we can now separate Pol encapsidation from the genome
and study genome incorporation separately.
In summary, we provide evidence that the FV IN domain
is not required for PR activity: First, expression of PR-RT
in cells is sufficient for Gag processing. Second, the PR ac-
tivity in vitro is RNAPARM dependent but IN independent.
Third, incorporation of PR-RT into viruses via a GagPR-RT
fusion protein leads to Gag cleavage in purified viruses.
Fourth, the PR activity can be encapsidated in trans as PR-RT molecule in the absence of the IN domain leading to
mature and infectious viruses.
Methods
In vitro PR activity assays
To determine proteolytic activity in vitro, PFV PR-RT
and the GB1-GFP substrate containing the RT-IN cleav-
age site between GB1 (immunoglobulin binding domain
B1 of the streptococcal protein G) and GFP (green fluor-
escence protein) were purified as described previously
[23-25]. In a first assay, 10 μM of the GB1-GFP sub-
strate was incubated for 2 h at 37°C in 50 mM
Na2HPO4/NaH2PO4 pH 6.4 and 100 mM NaCl with
2.5 μM PFV PR-RT in the presence or absence of
0.5 μM RNAPARM in a total volume of 20 μl. Reaction
products were separated by electrophoresis on 10% BisTris
gels (Invitrogen, Karlsruhe, Germany) in 50 mM 2-(N-
morpholino)ethanesulfonic acid buffer pH 7.3, 50 mM
Tris base, 0.1% SDS and 1 mM EDTA.
In a second assay, the conversion of the GB1-GFP sub-
strate was observed by measuring the change in fluores-
cence anisotropy of GFP upon cleavage of the substrate
(excitation wavelength: 395 nm; emission wavelength:
517 nm) in an L-format Jobin-Yvon Horiba Fluoromax
fluorimeter. Therefore, 10 μM GB1-GFP substrate was
incubated at 37°C in 50 mM Na2HPO4/NaH2PO4 pH 6.4
and 100 mM NaCl. After 30 min 2.5 μM PFV PR-RT
and after 60 min 0.5 μM of RNAPARM were added.
Plasmids and transfections
Codon-optimized prototypic FV gag (pcoPG4) [26], pol
(pcoPP) [11], env (pcoPE) [27] and the gfp encoding vec-
tor genome (pMD9) [14] plasmids were used. pGagPol:
In the first step the Gag/P3 cleavage site was added by
PCR using the primers PolHpaIs/PolHIa, Herculase II
polymerase (Stratagene) and pcoPP as template. The
product was digested with BamHI and cloned into the
BamHI/HpaI digested pcoPP vector. The resulting vector
was denominated as pcoCSPol. Then Gag was amplified
with the primers GagHIs and GagHIa. The product was
digested and cloned into the HpaI-site of the described
pcoCSPol vector. The resulting plasmid was verified by nu-
cleotide sequencing. pGagPR-RT: The Gag/P3 was added to
pol and a stop codon was cloned at the RT/IN CS by PCR
using the primers PolHpaIs and PolΔINNota. The PCR
product was cloned into the NotI/HpaI digested pcoPP vec-
tor. Then the Gag-coding sequence was added as described
above. pPR-RT: An AsiSI-restriction site was introduced
into pcoPP by site directed mutagenesis using the primers
PolHIs and PolAsiSIa and the Pol100a and PolAsiSIs re-
spectively. The PCR-product was digested with BamHI/
XhoI and ligated into the BamHI/XhoI digested pcoPP vec-
tor. The pcoPPΔIN vector was digested with AsiSI and
XhoI and the AsiSI/XhoI digested PCR product (primers:
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inserted 6 amino acid residues downstream of the PR RT-IN
cleavage site (YVVN/CNTKKAI-Stop) by ligation of the
INstop-oligo into the AsiSI site of pcoPP-AsiSI. pGagPolD/A
(Asp24>Ala): The catalytic centre of the PR was inactivated
by amplifying the pcoPol vector with the primers pcoAflIIs
and PolNarIa. The product was digested with AflII/NarI
and ligated into the AflII/NarI digested pcoPol vector. The
resulting pGagPolD/A vector was digested with HpaI and
ligated with the Gag fragment amplified with the primers
GagHIs and GagHpaw/ostop. pHSRV13ΔIN: In order to
delete the IN domain a AsiSI was introduced at position
5383–5389 of pHSRV13 by PCR mutagenesis using the pri-
mers HSRVAsiSIa and HSRVAsiSIs. In this site a stop
codon was introduces by self-complementary primer pStop,
resulting in a stop-codon at amino acid residue 562 of Pol.
All transfection reactions were performed using Tur-
bofect (Fermentas) and HEK 293 T or BHK cells as
described before [11].
Primers
PolHpaIs, AACACCGTGACCCAGATGAACCCCCTG
CAGCTGCTGCAGCC; PolHIa, TCTTGTCGTAGT
GGAACTGGATCCGGGG; PolΔINNota, AATTGCGG
CCGCTTAGTTCACCACGTAGGAGCCCTGGGTGG;
GagHIs, AACGGTGGAGGGCAGTGTAGTCTGAGC;
GagHIa, AACGGCTCTGTCCCGCTGGTCGCCGCCA
GAGGC; GagHpaIΔCSa, ACTGAATTCGTCCCGCTG
GTCGCCGCCAGAGGC; PolHIs, ATGACCTACCTG
GAAGATCCCCGG; PolAsiSIa, ATATCGCTCGAGT
CCAGCGATCGCCTTCTTGGTGTTGCAGTTCACC
ACG; PolAsiSIs, ATACGCGATCGCTAAGCCCAACC
TGGACGCCGAACTGG; Pol100a, TATTAGGAAAG
GACAGTGGGAGTGG; pcoAflIIs, ATGGAAGACT
TAAGGCA-GCGGC; Pol21ANarIa, ATGGTGGCGC
CGCTGGCCCAGTGGG; pStop, TTAACTAAGTAA
GGATCCTTACTTAGTTAAAT; HSRVAsiSIa, TATT
CCGGAATATGCGATCGCTTTTTTGGTATTACAAT
TAACTACATAACTTCCTTGGG; HSRVAsiSIs, ATA
GCGATCGCATGTAATACCAAAAAACCAAACCTG
GATGC.
Virus purification, infectivity assays, and western blotting
analysis
To purify virus particles, cell culture supernatants were cen-
trifuged at 474 x g to remove cells. The pre-cleared super-
natant were loaded on a 20% sucrose cushion and
centrifuged at 201,149 x g at 4°C for 2 h. To analyse the in-
fectivity cell culture supernatants were titrated on BHK cells
in triplicate assays. The number of GFP expressing cells was
determined after two days using a fluorescence microscope.
Viral titers were subsequently calculated.
Gag and Pol were detected using monoclonal antibodies
against Gag and RT as described before [11]. GAPDHamounts were visualized using an anti-GAPDH serum
(Sigma-Aldrich).
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